Sharon Bio-Medicine Ltd. - Research Center
532908 SHARONBIO Group (Z) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Mar ' 20 |
Sales |
93.00 |
94.13 |
94.27 |
79.06 |
85.08 |
Operating profit |
11.54 |
12.73 |
13.48 |
8.66 |
13.11 |
Interest |
0.04 |
0.05 |
0.06 |
0.09 |
0.10 |
Gross profit |
13.08 |
14.36 |
14.54 |
9.59 |
14.20 |
EPS (Rs) |
13.44 |
15.12 |
15.59 |
0.33 |
5.76 |
Half yearly
results in details
|
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Mar ' 20 |
Other income |
1.57 |
1.68 |
1.13 |
1.02 |
1.19 |
Stock adjustment |
-2.58 |
-2.29 |
0.53 |
-1.26 |
3.50 |
Raw material |
49.11 |
49.36 |
47.64 |
42.56 |
38.39 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
16.21 |
15.29 |
15.17 |
14.37 |
14.56 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
18.72 |
19.04 |
17.45 |
14.74 |
15.51 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
5.35 |
5.66 |
5.57 |
5.71 |
6.54 |
Taxation |
- |
- |
- |
- |
- |
Net profit / loss |
7.73 |
8.70 |
8.97 |
3.87 |
68.51 |
Extra ordinary item |
- |
- |
- |
- |
60.85 |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
1.15 |
1.15 |
1.15 |
23.79 |
23.79 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
12.41 |
13.52 |
14.30 |
10.95 |
15.42 |
GPM (%) |
13.83 |
14.99 |
15.24 |
11.97 |
16.46 |
NPM (%) |
8.18 |
9.08 |
9.40 |
4.84 |
79.42 |